本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

21.70
-0.3500-1.59%
盤後22.030.3300+1.52%19:09 EST
成交量:195.97萬
成交額:4,271.00萬
市值:27.46億
市盈率:60.59
高:22.55
開:22.05
低:21.54
收:22.05
52周最高:30.48
52周最低:16.10
股本:1.27億
流通股本:7,811.99萬
量比:1.03
換手率:2.51%
股息:- -
股息率:- -
每股收益(TTM):0.3581
每股收益(LYR):-1.5970
淨資產收益率:14.10%
總資產收益率:5.13%
市淨率:6.84
市盈率(LYR):-13.59

資料載入中...

2026/02/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities